The UK is missing its chance to become a life sciences superpower, experts have warned.
A report from the Medicines Manufacturing Industry Partnership says the government’s strategy for Britain’s £94bn life sciences sector is at risk of failing.
It added that unless ministers act to stem a loss of manufacturing investment, jobs and exports to international rivals, high hopes for the sector will not materialise.
It highlights the government’s Life Sciences Vision policy paper’s findings: production volumes down 29% and more than 7,000 jobs lost since 2009. The UK has also dropped from fourth to 98th in the overall trade balance in pharmaceuticals.
